Tanna Nuttan Kantilal, Ong Terence
Northwick Park Hospital, London North West University Healthcare NHS Trust, London, United Kingdom.
Department of Medicine, Faculty of Medicine, University Malaya, 50603, Kuala Lumpur, Malaysia.
Osteoporos Sarcopenia. 2022 Sep;8(3):93-97. doi: 10.1016/j.afos.2022.09.003. Epub 2022 Oct 3.
This review considers the evidence base and current knowledge for pharmacological treatment options that are available for pain control in patients with vertebral fractures sustained after a low trauma incident. Due care needs to be taken when considering prescribed options for pain control. The decision should be based on first establishing whether the presentation is one of acute severe pain at the time of a new vertebral fragility fracture incident or whether the complaint is one of the debilitating, longer term chronic back pain syndrome, accompanied by a clinical suspicion of a possible new fracture. The article also presents currently debated questions in this important area of clinical and patient care and will be of interest to the readership worldwide.
本综述探讨了低创伤事件后发生椎体骨折的患者疼痛控制可用药物治疗方案的证据基础和当前知识。在考虑规定的疼痛控制方案时需要格外谨慎。该决定应首先基于确定症状是新的椎体脆性骨折事件时的急性剧痛，还是伴有可能新发骨折临床怀疑的衰弱性长期慢性背痛综合征。本文还提出了这一临床和患者护理重要领域当前存在争议的问题，全球读者可能会感兴趣。
